Increased Lipoprotein Lipase Activity in Non-small Cell Lung Cancer Tissue Predicts Shorter Patient Survival

Archives of Medical Research

Volumn 40, Issue 5, 2009, Pages 364-368

  Trost, Zoran ^a   Sok, Miha ^b   Marc, Janja ^a   Cerne, Darko ^a  

^a UNIVERSITY OF LJUBLJANA   (Slovenia)

^b UNIVERSITY MEDICAL CENTRE LJUBLJANA   (Slovenia)

Author keywords

Enzyme activity; Gene expression; Lipoprotein lipase; Lung cancer tissue; Patient survival

Indexed keywords

LIPOPROTEIN LIPASE; TUMOR MARKER;

ADULT; AGED; ARTICLE; CANCER GROWTH; CANCER MORTALITY; CANCER SURVIVAL; CANCER TISSUE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE MARKER; ENZYME ACTIVITY; FEMALE; FOLLOW UP; HUMAN; HUMAN TISSUE; LUNG NON SMALL CELL CANCER; MALE; PROGNOSIS; PROTEIN EXPRESSION; SURVIVAL TIME;

ADULT; AGED; CARCINOMA, NON-SMALL-CELL LUNG; FEMALE; FOLLOW-UP STUDIES; HUMANS; LIPOPROTEIN LIPASE; LUNG NEOPLASMS; MALE; MIDDLE AGED; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; REGRESSION ANALYSIS; SURVIVAL ANALYSIS;

EID: 70349133488     PISSN: 01884409     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.arcmed.2009.05.001     Document Type: Article

References (29)

1. Sakayama K., Masuno H., Miyazaki T., et al. Existence of lipoprotein lipase in human sarcomas and carcinomas. Jpn J Cancer Res 85 (1994) 515-521
2. Cerne D., Melkic E., Trost Z., et al. Lipoprotein lipase activity and gene expression in lung cancer and in adjacent noncancer lung tissue. Exp Lung Res 33 (2007) 217-225
3. Obeid O.A., and Emery P.W. Lipid metabolism in cachectic tumor-bearing rats at different stages of tumor growth. Nutr Cancer 19 (1993) 87-98
4. Nomura K., Noguchi Y., and Matsumoto A. Stimulation of decreased lipoprotein lipase activity in the tumor-bearing state by the antihyperlipidemic drug bezafibrate. Surg Today 26 (1996) 89-94
5. Van Bockstaele F., Pede V., Janssens A., et al. Lipoprotein lipase mRNA expression in whole blood is a prognostic marker in B cell chronic lymphocytic leukemia. Clin Chem 53 (2007) 204-212
6. Niho N., Takahashi M., Kitamura T., et al. Concomitant suppression of hyperlipidemia and intestinal polyp formation in Apc-deficient mice by peroxisome proliferator-activated receptor ligands. Cancer Res 63 (2003) 6090-6095
7. Mutoh M., Niho N., and Wakabayashi K. Concomitant suppression of hyperlipidemia and intestinal polyp formation by increasing lipoprotein lipase activity in Apc-deficient mice. Biol Chem 387 (2006) 381-385
8. Sobin L.H., and Wittekind C. TNM Classification of Malignant Tumours. 6th ed (2002), John Wiley & Sons, Hoboken, NJ
9. Travis W.D., Brambilla E., Muller-Hermelink H.K., et al. World Health Organization Classification of Tumours. Pathology and Genetics of Tumours of the Lung, Pleura, Thymus and Heart (2004), IARC Press, Lyon, France
10. Bilac Krasnja M., and Cerne D. Optimization of an analytical procedure of lipoprotein lipase activity measurement in cancer tissue. Farm Vestn 60 (2009) 21-26
11. Narita S., Tsuchiya N., Wang L., et al. Association of lipoprotein lipase gene polymorphism with risk of prostate cancer in a Japanese population. Int J Cancer 112 (2004) 872-876
12. Zeng X., Wu S.F., Xu Q., et al. Relationship between chromosome 8 alterations and Gleason score in prostatic adenocarcinoma. Zhonghua Bing Li Xue Za Zhi 35 (2006) 523-528
13. Preiss-Landl K., Zimmermann R., Hammerle G., et al. Lipoprotein lipase: the regulation of tissue specific expression and its role in lipid and energy metabolism. Curr Opin Lipidol 13 (2002) 471-481
14. Niho N., Mutoh M., Komiya M., et al. Improvement of hyperlipidemia by indomethacin in Min mice. Int J Cancer 121 (2007) 1665-1669
15. Sakayama K., Mashima N., Kidani T., et al. Effect of cortisol on cell proliferation and the expression of lipoprotein lipase and vascular endothelial growth factor in a human osteosarcoma cell line. Cancer Chemother Pharmacol 61 (2008) 471-479
16. Mulligan H.D., and Tisdale M.J. Effect of the lipid-lowering agent bezafibrate on tumour growth rate in vivo. Br J Cancer 64 (1991) 1035-1038
17. Gann P.H., Hennekens C.H., Sacks F.M., et al. Prospective study of plasma fatty acids and risk of prostate cancer. J Natl Cancer Inst 86 (1994) 281-286
18. Lanza-Jacoby S., Lansey S.C., Miller E.E., et al. Sequential changes in the activities of lipoprotein lipase and lipogenic enzymes during tumor growth in rats. Cancer Res 44 (1984) 5062-5067
19. Noguchi Y., Vydelingum N.A., Younes R.N., et al. Tumor-induced alterations in tissue lipoprotein lipase activity and mRNA levels. Cancer Res 51 (1991) 863-869
20. Tisdale M.J. Wasting in cancer. J Nutr 129 (1999) 243S-246S
21. Nara-Ashizawa N., Akiyama Y., Maruyama K., et al. Lipolytic and lipoprotein lipase (LPL)-inhibiting activities produced by a human lung cancer cell line responsible for cachexia induction. Anticancer Res 21 (2001) 3381-3387
22. Lookene A., Zhang L., Hultin M., et al. Rapid subunit exchange in dimeric lipoprotein lipase and properties of the inactive monomer. J Chem 279 (2004) 49964-49972
23. Sukonina V., Lookene A., Olivecrona T., et al. Angiopoietin-like protein 4 converts lipoprotein lipase to inactive monomers and modulates lipase activity in adipose tissue. Proc Natl Acad Sci USA 103 (2006) 17450-17455
24. Wu G., Brouckaert P., and Olivecrona T. Rapid downregulation of adipose tissue lipoprotein lipase activity on food deprivation: evidence that TNF-alpha is involved. Am J Physiol Endocrinol Metab 286 (2004) E711-E717
25. Wu G., Zhang L., Gupta J., et al. A transcription-dependent mechanism, akin to that in adipose tissue, modulates lipoprotein lipase activity in rat heart. Am J Physiol Endocrinol Metab 293 (2007) E908-E915
26. Kota R.S., Ramana C.V., Tenorio F.A., et al. Differential effects of lipoprotein lipase on tumor necrosis factor-alpha and interferon-gamma-mediated gene expression in human endothelial cells. J Biol Chem 280 (2005) 31076-31084
27. Kim S.J., Nian C., and McIntosh C.H. Resistin is a key mediator of glucose-dependent insulinotropic polypeptide (GIP) stimulation of lipoprotein lipase (LPL) activity in adipocytes. J Biol Chem 282 (2007) 34139-34147
28. Savage D.B., Sewter C.P., Klenk E.S., et al. Resistin/Fizz3 expression in relation to obesity and peroxisome proliferator-activated receptor-gamma action in humans. Diabetes 50 (2001) 2199-2202
29. Tabano S., Alvino G., Antonazzo P., et al. Placental LPL gene expression is increased in severe intrauterine growth-restricted pregnancies. Pediatr Res 59 (2006) 250-253